Inventor · disambiguated record
Ruth Salmon
Also filed as: SALMON RUTH · SALMON RUTH AMANDA
3 granted patents·9 pending applications·12 citations·filing 2017–2025
62Inventor score
Files withJUNO THERAPEUTICS INC12
Top patents by PatentIndex Score
12 records- 0191US11066475B2Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotidesJUNO THERAPEUTICS INC·Filed 2018·Granted Jul 20, 2021·10 cites·23 claims
- 0276US11590167B2Methods and compositions for use of therapeutic T cells in combination with kinase inhibitorsJUNO THERAPEUTICS INC·Filed 2017·Granted Feb 28, 2023·2 cites·37 claims
- 0363US2024226298A1Chimeric antigen receptors specific for baff-r and cd19 and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0461US12428486B2Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotidesJUNO THERAPEUTICS INC·Filed 2021·Granted Sep 30, 2025·0 cites·22 claims
- 0560US2024016840A1Methods and compositions for use of therapeutic t cells in combination with kinase inhibitorsJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0651US2025345431A1Genetically engineered t cells expressing a cd19 chimeric antigen receptor (car) and uses thereof for allogeneic cell therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0745US2023190798A1Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0845US2022225597A1Mouse model for assessing toxicities associated with immunotherapiesJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0945US2023087953A1Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1037US2019136230A1Genetically engineered cells and methods of making the sameJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1134US2019298772A1Combination therapy of a t cell-based therapy and a btk inhibitorJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1233US2020078404A1Combination of a cell therapy and an immunomodulatory compoundJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ruth Salmon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →